Skip to main content
Equibles

MetLife Investment Management, LLC

Position in SGHT — Sight Sciences, Inc.

CIK 1529735 Whippany, NJ
Back to SGHT Full portfolio

Position in SGHT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$128,833
+$64,118 QoQ
Shares Held
23,770
+38.5% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 111 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGHT Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $231,772,552 across 68 Medical Devices names. SGHT ranks #64 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 398,341 $36,145,462
2 SYK
Stryker Corp
 78,948 $24,855,988
3 MDT
Medtronic plc
 293,703 $22,976,385
4 BRKR
Bruker Corp
 374,119 $22,514,481
5 GMED
Globus Medical Inc
 275,556 $21,771,679
6 BSX
Boston Scientific Corp
 339,986 $14,510,602
7 EW
Edwards Lifesciences Corp
 131,633 $11,907,521
8 DXCM
Dexcom Inc
 103,307 $6,957,726

All Filings in SGHT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $128,833 23,770
2026-03-31 $64,715 17,166
2025-12-31 $148,037 18,668
2025-09-30 $86,612 25,178
2025-06-30 $111,662 27,037
2024-09-30 $134,964 21,423
2024-06-30 $142,891 21,423
2023-06-30 $101,148 12,216
2023-03-31 $106,767 12,216
2022-12-31 $149,157 12,216
2022-06-30 $129,132 14,364
2022-03-31 $166,047 14,364
2021-09-30 $107,529 4,737